KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 23, 2026 >>  ABB India 6140  [ -4.95% ]  ACC 1158.55  [ -2.38% ]  Ambuja Cements 358  [ 0.69% ]  Asian Paints 2305  [ 0.59% ]  Axis Bank 1214.05  [ 0.48% ]  Bajaj Auto 10080  [ -0.52% ]  Bank of Baroda 231  [ -1.89% ]  Bharti Airtel 1890  [ -0.52% ]  Bharat Heavy 387  [ -2.84% ]  Bharat Petroleum 281.25  [ -1.83% ]  Britannia Industries 4547.8  [ -1.99% ]  Cipla 1337  [ 0.53% ]  Coal India 397.75  [ -1.08% ]  Colgate Palm 1604  [ -4.81% ]  Dabur India 366  [ -0.85% ]  DLF 653.55  [ -1.66% ]  Dr. Reddy's Lab. 1224.5  [ -1.17% ]  GAIL (India) 163.3  [ -2.74% ]  Grasim Industries 2898  [ 0.77% ]  HCL Technologies 1424  [ -0.14% ]  HDFC Bank 692.1  [ -0.17% ]  Hero MotoCorp 5035.35  [ -1.64% ]  Hindustan Unilever 1820  [ -0.76% ]  Hindalco Industries 860.5  [ -3.10% ]  ICICI Bank 1395  [ 0.01% ]  Indian Hotels Co. 784  [ 0.09% ]  IndusInd Bank 835  [ -1.76% ]  Infosys 1154.5  [ 0.30% ]  ITC 257.2  [ -0.41% ]  Jindal Steel 1012  [ -1.72% ]  Kotak Mahindra Bank 430.1  [ -1.70% ]  L&T 3645  [ 1.25% ]  Lupin 1925  [ -0.16% ]  Mahi. & Mahi 2848  [ -0.23% ]  Maruti Suzuki India 11258.95  [ 0.54% ]  MTNL 22.82  [ -7.05% ]  Nestle India 1173.45  [ -1.39% ]  NIIT 73.49  [ -5.69% ]  NMDC 66.3  [ -3.77% ]  NTPC 298  [ -1.28% ]  ONGC 226  [ 0.51% ]  Punj. NationlBak 120.35  [ -1.59% ]  Power Grid Corpn. 247.2  [ -0.16% ]  Reliance Industries 1190  [ 1.19% ]  SBI 957  [ -1.17% ]  Vedanta 226  [ -3.00% ]  Shipping Corpn. 237.95  [ -5.63% ]  Sun Pharmaceutical 1743  [ -0.62% ]  Tata Chemicals 575.5  [ -3.12% ]  Tata Consumer 960  [ -0.31% ]  Tata Motors Passenge 265.45  [ -1.50% ]  Tata Steel 167.25  [ -3.21% ]  Tata Power Co. 346  [ -2.12% ]  Tata Consult. Serv. 2528  [ 1.00% ]  Tech Mahindra 1789.4  [ -1.95% ]  UltraTech Cement 11066  [ 0.83% ]  United Spirits 1250.45  [ -2.45% ]  Wipro 189.75  [ -0.13% ]  Zee Entertainment 65.45  [ -4.42% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

ALPA LABORATORIES LTD.

23 October 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE385I01010 BSE Code / NSE Code 532878 / ALPA Book Value (Rs.) 89.00 Face Value 10.00
Bookclosure 29/09/2025 52Week High 94 EPS 7.13 P/E 6.91
Market Cap. 103.71 Cr. 52Week Low 46 P/BV / Div Yield (%) 0.55 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited".

In the year 1997, we initiated setting of a new manufacturing unit at 33/2, Pigdamber, A.B. Road, Rau, District Indore, Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams.

We manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. We also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, we also undertake contract manufacturing of a large variety of pharmaceuticals.

We manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. We have an established product-marketing network covering both metro and mini metro cities, which enable us to reach our existing and potential customers through our network of distributors and dealers spread across the country. For the purpose of marketing the various products, our Company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division.

HISTORY AND MAJOR EVENTS

1988        Incorporation of Alpa Laboratories Private Limited
1997        Commenced setting up of manufacturing facility at 
                Pigdamber, Indore
1998        Conversion to Alpa Laboratories Limited, a public limited 
                company
1999        Start of commercial production
 2001       WHO GMP Certification for its manufacturing facilities
                Entered into an agreement for Contract manufacturing 
                at its newly constructed facility, with Plethico 
                Pharmaceuticals Ltd., a Pharmaceutical company, for
                manufacturing its various range of products.
                The manufacturing facilities at Pigdamber were certified 
               as WHO GMP compliant by SGS-ICS Belgium for the 
               period 2001-02.
2003       Certified ISO 9001: 2000*
               The manufacturing facility at Pigdamber was approved by 
               the Director General of Quality Assurance (DGQA), India 
               thereby opening its doors for participating in Tenders for 
              supplies to defence institutions**
              Started export of its Veterinary products and registered its 7 
              veterinary products in Sudan
2006      Started participation in international tenders for export in 
              addition to domestic marketing abroad and won a major 
              tender from CMS, Sudan. Launched Veterinary Division 
              with a new face and ethical promotion of its Veterinary 
              products launched in 5 states in the year 2006.
              Launched Ethical division for its human products
            * Expired on May 14, 2006
            ** Expired on January 22, 2006. This certificate is not 
             required now as our revenue have crossed Rs 2000.00 
             lakhs as per DGQA norms.
2007

-Alpa Laboratories ties up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products.

2010

- The Company has recommended dividend of 10%.

2014

- Ms. Monali Patel, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as the Company Secretary and Compliance Officer.

- Alpa Laboratories has sold its Unit-II ("Undertaking) situated at Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale basis to Ipca Laboratories Limited.

2015 -Alpa Laboratories Ltd has formed a wholly owned subsidiary under the name and style of Norfolk Mercantile Private Ltd.